Trump admin releases cleaned-up health pricing rules — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- The Trump administration released new regulations Monday requiring health insurers to publish cleaned-up spreadsheets of prices paid to hospitals and doctors, stripping out meaningless data that had previously clogged the files.
- Mehmet Oz, head of Medicare and Medicaid, said at a Monday event that the government will begin developing a prescription drug price disclosure system next month.
- The drug pricing rollout targets a "hopeful" final plan by next May, with government enforcement of the requirements set for the end of 2027.
- Pharmaceutical companies and pharmacy benefit managers won a victory last year when the Trump administration punted on finalizing drug price disclosure rules, given their fierce resistance to price transparency.
Why it matters: The cleaned-up hospital and doctor pricing files address widespread complaints that earlier transparency files were clogged with junk data, giving employers, researchers, and patients clearer visibility into what insurers actually pay providers. The separate drug pricing push, with enforcement targeted by end of 2027, directly confronts the negotiated-price opacity that drug companies and PBMs have successfully fought to preserve.
Ask SkimNews
